kabutan

Renascience, Ordinary Profit Forecast for the Fiscal Year Loss to Narrow

Wed Nov 12, 2025 3:30 pm JST Earnings

4889 Renascience Inc. 【J-GAAP】

Earnings Report

Renascience Inc. <4889> [TSE Growth] announced its financial results after the market closed on November 12th (15:30). The ordinary loss (non-consolidated) for the cumulative second quarter of the fiscal year ending March 2026 (April to September) expanded to a loss of 151 million yen (compared to a loss of 92 million yen in the same period last year).

However, the full-year forecast for ordinary profit/loss has been revised upward from an expected loss of 360 million yen to a loss of 343 million yen (compared to a loss of 178 million yen in the previous period), indicating a reduction in the loss margin.

Based on the first-half performance announced by the company and the full-year plan, our calculation indicates that the ordinary loss for the October to March period (second half) is expected to expand to a loss of 192 million yen (compared to a loss of 86 million yen in the same period last year).

In the most recent three-month period, from July to September (2Q), the ordinary loss expanded to loss of 85 million yen (compared to a loss of 56 million yen in the same period last year).

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2023 120 -94 -94 -95 -7.5 ー Nov 9, 2023 J-GAAP
Apr - Sep, 2024 55 -90 -92 -72 -5.7 ー Nov 14, 2024 J-GAAP
Apr - Sep, 2025 10 -188 -151 -151 -11.9 ー Nov 12, 2025 J-GAAP
YoY -81.8% -108.9% -64.1% -109.7% -108.0%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 Guidance ー ー ー ー － 0 May 14, 2025 J-GAAP
Apr - Sep, 2025 Results 10 -188 -151 -151 -11.9 0 Nov 12, 2025 J-GAAP
Revision Rate － － － － －

Guidance Update

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Prev 113 -397 -360 -362 -28.5 0 May 14, 2025 J-GAAP
Mar, 2026 New 133 -380 -343 -345 -27.1 0 Nov 12, 2025 J-GAAP
Revision Rate +17.7% +4.3% +4.7% +4.7% +4.7%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 77 -88 -86 185 14.6 0 May 14, 2025 J-GAAP
Oct - Mar, 2025 Guidance 123 -192 -192 -194 -15.3 0 Nov 12, 2025 J-GAAP
YoY +59.7% -118.2% -123.3% － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 194 -252 -251 -258 -20.3 0 May 9, 2024 J-GAAP
Mar, 2025 132 -178 -178 113 8.9 0 May 14, 2025 J-GAAP
Mar, 2026 Guidance 133 -380 -343 -345 -27.1 0 Nov 12, 2025 J-GAAP
YoY +0.8% -113.5% -92.7% － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2024 15 -54 -56 -56 -4.5 -360.0 Nov 14, 2024 J-GAAP
Oct - Dec, 2024 10 -49 -48 226 17.8 -490.0 Feb 13, 2025 J-GAAP
Jan - Mar, 2025 67 -39 -38 -41 -3.2 -58.2 May 14, 2025 J-GAAP
Apr - Jun, 2025 10 -102 -66 -66 -5.3 -1,020.0 Aug 13, 2025 J-GAAP
Jul - Sep, 2025 0 -86 -85 -85 -6.7 -Inf Nov 12, 2025 J-GAAP
YoY － -59.3% -51.8% -51.8% -50.7%

Related Articles